objective to evaluate the efficacy of preparations with avocadosoybean unsaponifiables asus in osteoarthritis oa patients using metaanalysis on randomized controlled trials rctsmethod rcts from systematic searches were included if they explicitly stated that hip andor knee oa patients were randomized to either asu or placebothe coprimary outcome was reduction in pain and lequesne index leading to effect size es calculated as the standardized mean differenceas secondary analysis the number of responders to therapy was analyzed as odds ratios orsrestricted maximum likelihood methods were applied for the metaanalyses using mixed effects modelsresults four trialsall supported by the manufacturerwere included with 664 oa patients with either hip 414 or knee 586 oa allocated to either 300 mg asu 336 or placebo 328average trial duration was 6 months range 312 monthsthough based on heterogeneous results the combined pain reduction favored asu i2  835 es  039 95 confidence intervals 001076 p004applying the lequesne index also favored asu i2  610 es  045 021070 p  00003secondarily the number of responders following asu compared to placebo or  219 p  0007 corresponded to a number needed to treat of six 421 patientsconclusions based on the available evidence patients may be recommended to give asu a chance for eg 3 monthsmetaanalysis data support better chances of success in patients with knee oa than in those with hip oa